Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 7 de 7
Filtrar
Más filtros











Intervalo de año de publicación
1.
Bol. latinoam. Caribe plantas med. aromát ; 22(5): 636-648, sep. 2023. mapas, ilus, tab, graf
Artículo en Español | LILACS | ID: biblio-1561290

RESUMEN

In the high Andean areas, the main economic activity is alpaca raising, which is affected by various infectious and parasitic diseases. Rural populations often resort to wild plants that have diverse properties and help control various diseases. The objective was to document the uses of wild plants in the control of alpaca diseases in the high Andean areas of the Puno and Arequipa regions. Fifty alpaca-breeding families were interviewed in five localities. Thirty-two species belonging to 16 families were reported, with the Asteraceae and Fabaceae families having the highest number of species. The most frequently treated pathologies were diarrhea, pneumonia, fever and enteric parasitosis. For diarrhea treatment, the most used plants were M. mollis, S. nutans and T. filifolia, for pneumonia were G. prostrata and G. viravira, for enteric parasitosis were B. tricuneata and L. daucifolia and for the elimination of ectoparasites (lice) was A. compacta. For all diseases, the treatment dose was higher in adults than in neonates and its application is in the rainy season. In acute disease conditions, rural families choice to drugs. Wild plants are a viable and sustainable alternative for the treatment of various diseases in alpacas.


En las zonas altoandinas la principal actividad económica es la crianza de alpacas, las mismas que son afectadas por diversas enfermedades infecciosas y parasitarias. Las poblaciones rurales frecuentemente recurren a las plantas silvestres que tienen diversas propiedades y ayudan al control de diversas enfermedades. El objetivo fue documentar los usos de las plantas silvestres en el control de enfermedades de alpacas en las zonas altoandinas de la región Puno y Arequipa. Se entrevistó a 50 familias criadoras de alpacas en cinco localidades. Se reportaron 32 especies, pertenecientes a 16 familias, siendo la familia Asteraceae y Fabaceae con mayor número de especies. Las patologías que con mayor frecuencia se tratan fueron la diarrea, neumonía, fiebre y parasitosis entérica. Para el tratamiento de diarrea, las plantas más utilizadas fueron M. mollis, S. nutans y T. filifolia, para la nuemonía fueron G. prostrata y G. viravira, para parasitosis entérica fueron B. tricuneata y L. daucifolia y para la eliminación de ectoparásitos (piojos) fue A. compacta. Para todas las enfermedades, las dosis de tratamiento fueron superior en las adultas que en las crías y su aplicación es en la época de lluvias. En condiciones agudas de las enfermedades las familias rurales recurren a los fármacos. Las plantas silvestres, son una alternativa viable y sostenible para el tratamiento de diversas enfermedades en alpacas.


Asunto(s)
Animales , Plantas Medicinales , Camélidos del Nuevo Mundo , Enfermedades de los Animales/tratamiento farmacológico , Medicina Tradicional , Perú , Encuestas y Cuestionarios , Enfermedades de los Animales/prevención & control
2.
Braz. J. Vet. Res. Anim. Sci. (Online) ; 59: e176998, fev. 2022. tab, ilus
Artículo en Inglés | VETINDEX, LILACS | ID: biblio-1397329

RESUMEN

The poultry industry suffers from various diseases or stresses. In poultry, apart from being antipyretic, acetylsalicylic acid (ASA) is widely used to cope with different issues including heat stress, and respiratory and digestive orders. This study evaluated the beneficial and toxic effects of ASA at different dose levels in broiler birds. To evaluate these toxic and beneficial effects it is necessary to examine the physical and serum biochemical parameters as well as the histopathological changes with tissue sections taken from broiler birds under experimental trial. This study was conducted on 60 one-day-old broiler chicks purchased from a local market in Faisalabad. Chicks were reared for the first 14 days under similar conditions. On the 15th day, birds were randomly divided into 4 groups (1-4) with 15 birds in each group. Group 4 was kept as control, while groups 1, 2, and 3 were treated with ASA at the dose of 300, 600, and 1200 mg/L of drinking water for 21 days. There were 3 samplings performed at 21, 28, and 35 days post-treatment. The live body weight and carcass weight were noted on each sampling. All the visceral organs were recorded for gross pathological changes. The serum samples were collected for biochemical evaluation. Histopathology of all the visceral organs was performed to observe the microscopic changes. A significant (P<0.05) increase in live body weight at a 300mg/L dose was noted after the first 2 samplings. A significant (P<0.05) increase in the relative organ weight was recorded at 1200 mg/L. The groups treated with ASA 600 and 1200 mg/L showed increased (P<0.05) AST, ALT, and creatinine levels from that of the control group. The group treated with 1200 mg/L of ASA showed increased (P<0.05) urea, serum total protein, and albumin level in all the samplings. Histopathological changes revealed swollen hepatocytes, increased sinusoidal spaces in the liver, congestion and abnormal glomerular spaces in the kidney, congestion and alveolar disruption in the lungs, and generation of villi and cellular degeneration in the intestine in a high-dose group. The study concluded that ASA at a low dose can be used for a long time in broilers and has a growth promontory role, while high-level doses cause hepatorenal toxicity.(AU)


A indústria avícola é afetada por diversas doenças ou estresses. Particularmente devido às aves serem antipiréticas. O ácido acetil salicílico (AAS) é largamente utilizado com diferentes objetivos que incluem o controle do estresse calórico, bem como a atividade respiratória e digestiva. O propósito deste estudo foi a avaliação dos efeitos benéficos e tóxicos do emprego de diferentes dosagens do AAS em frangos de corte. As variáveis analisadas foram: exame físico, parâmetros bioquímicos, bem como as alterações histopatológica em seções de tecidos colhidas das aves em um ensaio experimental. O estudo foi conduzido em 60 frangos de corte com um dia de idade adquiridos em um mercado local de Faisalabad que foram recriados nos primeiros 14 dias em idênticas condições. Então no 15º dia as aves foram distribuídas randomicamente em quatro grupos identificados pelos números 1 a 4, com 15 aves em cada grupo. O grupo 4 foi mantido como grupo controle e os grupos 1, 2 e 3 foram tratados com AAS, respectivamente, nas doses de 300, 600 e 1200 mg/L de água de bebida, durante 21 dias. Foram realizadas três amostragens nos dias 21, 28 e 35 pós-tratamento. O peso vivo corpóreo e da carcaça foi registrado em cada amostragem. Em todos os órgãos viscerais foi analisada a presença de alterações patológicas. As amostras de soro sanguíneo foram colhidas para a avaliação bioquímica. O exame histopatológico de todos os órgãos viscerais foi realizado para a observação de alterações microscópicas. A partir da segunda amostragem foi observado um aumento significante (p<0,05) no peso corpóreo na dosagem de 300mg/L. Um significante aumento no peso relativo dos órgãos foi registrado na dosagem de 1200 mg/L. Os grupos tratados com dosagens de 600 e 1200 mg/L de AAS, apresentaram aumento significante dos níveis de AST, ALT e de creatinina quando comparados ao grupo controle. O grupo tratado com 1200 mg/L de AAS apresentou um aumento significante (P,0,05) de uréia, proteína sérica total e de albumina em todas as amostragens. No grupo de alta dosagem foram observados alterações histopatológicas constituídas por aumento dos hepatócitos, aumento dos espaços sinusoidais no fígado, congestão e anormalidades nos espaços glomerulares nos rins, congestão e ruptura alveolar nos pulmões, degeneração das vilosidades e celular nos intestinos A conclusão obtida foi que em frangos de corte uma baixa dosagem do AAS pode ser utilizada por um período de longa duração, apresentando um efeito promotor do crescimento, contudo as doses elevadas determinam toxicidade hepática e renal.(AU)


Asunto(s)
Animales , Pollos , Aspirina/administración & dosificación , Aspirina/efectos adversos , Enfermedades de los Animales/tratamiento farmacológico , Pakistán , Serología , Bioquímica/métodos
3.
Curr Protein Pept Sci ; 20(4): 304-315, 2019.
Artículo en Inglés | MEDLINE | ID: mdl-30370845

RESUMEN

Triosephosphate isomerase is the fifth enzyme in glycolysis and its canonical function is the reversible isomerization of glyceraldehyde-3-phosphate and dihydroxyacetone phosphate. Within the last decade multiple other functions, that may not necessarily always involve catalysis, have been described. These include variations in the degree of its expression in many types of cancer and participation in the regulation of the cell cycle. Triosephosphate isomerase may function as an auto-antigen and in the evasion of the immune response, as a factor of virulence of some organisms, and also as an important allergen, mainly in a variety of seafoods. It is an important factor to consider in the cryopreservation of semen and seems to play a major role in some aspects of the development of Alzheimer's disease. It also seems to be responsible for neurodegenerative alterations in a few cases of human triosephosphate isomerase deficiency. Thus, triosephosphate isomerase is an excellent example of a moonlighting protein.


Asunto(s)
Anemia Hemolítica Congénita no Esferocítica/veterinaria , Enfermedades de los Animales/enzimología , Errores Innatos del Metabolismo de los Carbohidratos/veterinaria , Triosa-Fosfato Isomerasa/deficiencia , Triosa-Fosfato Isomerasa/metabolismo , Anemia Hemolítica Congénita no Esferocítica/tratamiento farmacológico , Anemia Hemolítica Congénita no Esferocítica/metabolismo , Enfermedades de los Animales/tratamiento farmacológico , Animales , Errores Innatos del Metabolismo de los Carbohidratos/tratamiento farmacológico , Errores Innatos del Metabolismo de los Carbohidratos/metabolismo , Dihidroxiacetona Fosfato/metabolismo , Gliceraldehído 3-Fosfato/metabolismo , Glucólisis , Humanos
4.
PLoS One ; 11(11): e0166402, 2016.
Artículo en Inglés | MEDLINE | ID: mdl-27846314

RESUMEN

The depletion times of enrofloxacin and its metabolite ciprofloxacin as well as sulfaquinoxaline and oxytetracycline were evaluated in broiler chickens that had been subjected to pharmacological treatment. The presence and residue levels of these drugs in muscle tissue were evaluated using an ultra-performance liquid chromatography-tandem mass spectrometry (UPLC-MS/MS) method that was validated in this work. The results showed the presence of all antimicrobial residues; however, the presence of residues at concentrations higher than the drugs' maximum residue limit (MRL) of 100 µg kg-1 was found only during the treatment period for oxytetracycline and until two days after discontinuation of the medication for enrofloxacin, ciprofloxacin and sulfaquinoxaline. It was concluded that the residues of all antimicrobials were rapidly metabolized from the broiler muscles; after four days of withdrawal, the levels were lower than the limit of quantification (LOQ) of the method for the studied analytes.


Asunto(s)
Enfermedades de los Animales/tratamiento farmacológico , Antiinfecciosos/administración & dosificación , Pollos/microbiología , Inactivación Metabólica , Enfermedades de los Animales/microbiología , Animales , Antiinfecciosos/aislamiento & purificación , Ciprofloxacina/administración & dosificación , Ciprofloxacina/aislamiento & purificación , Residuos de Medicamentos/química , Residuos de Medicamentos/aislamiento & purificación , Enrofloxacina , Fluoroquinolonas/administración & dosificación , Fluoroquinolonas/aislamiento & purificación , Músculos/química , Músculos/efectos de los fármacos , Oxitetraciclina/administración & dosificación , Oxitetraciclina/aislamiento & purificación , Sulfaquinoxalina/administración & dosificación , Sulfaquinoxalina/aislamiento & purificación
5.
Pharm Biol ; 50(10): 1269-75, 2012 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-22873798

RESUMEN

CONTEXT: Medicinal plants are well known for their use in traditional folk medicine as treatments for many diseases including infectious diseases. OBJECTIVE: Six Brazilian medicinal plant species were subjected to an antiviral screening bioassay to investigate and evaluate their biological activities against five viruses: bovine herpesvirus type 5 (BHV-5), avian metapneumovirus (aMPV), murine hepatitis virus type 3, porcine parvovirus and bovine respiratory syncytial virus. MATERIALS AND METHODS: The antiviral activity was determined by a titration technique that depends on the ability of plant extract dilutions (25 or 2.5 µg/mL) to inhibit the viral induced cytopathic effect and the extracts' inhibition percentage (IP). RESULTS: Two medicinal plant species showed potential antiviral activity. The Aniba rosaeodora Ducke (Lauraceae) extract had the best results, with 90% inhibition of viral growth at 2.5 µg/mL when the extract was added during the replication period of the aMPV infection cycle. The Maytenus ilicifolia (Schrad.) Planch. (Celastraceae) extracts at a concentration of 2.5 µg/mL exhibited antiviral activity during the attachment phase of BHV-5 (IP = 100%). DISCUSSION AND CONCLUSION: The biomonitored fractionation of the active extracts from M. ilicifolia and A. rosaeodora could be a potential tool for identifying their active compounds and determining the exact mechanism of action.


Asunto(s)
Antivirales/farmacología , Extractos Vegetales/farmacología , Plantas Medicinales/química , Enfermedades de los Animales/tratamiento farmacológico , Enfermedades de los Animales/virología , Animales , Antivirales/administración & dosificación , Antivirales/aislamiento & purificación , Brasil , Bovinos , Relación Dosis-Respuesta a Droga , Herpesvirus Bovino 5/efectos de los fármacos , Lauraceae/química , Maytenus/química , Medicina Tradicional , Metapneumovirus/efectos de los fármacos , Ratones , Extractos Vegetales/administración & dosificación , Porcinos , Replicación Viral/efectos de los fármacos
6.
Vet Res ; 29(5): 409-30, 1998.
Artículo en Inglés | MEDLINE | ID: mdl-9779555

RESUMEN

The development of drug resistance and the inability of the drug to reach the location of the etiologic agents are major challenges for anti-infective and cancer therapies. As the development of new drugs with improved pharmacodynamic and pharmacokinetic properties is a slow and difficult process, drug delivery systems appear as promising alternatives. Liposomes are lipid vesicles formed when phospholipids are exposed to an aqueous environment. They arrange themselves in bilayers and close up, forming a vesicle. During this process they capture the aqueous phase of the dispersion, and any substance dissolved in it, within the vesicle. Liposomes have remarkable features that make them an almost ideal delivery system. They are biodegradable, with few side effects, can deliver drugs with different physico-chemical properties together and can be formulated for different routes of administration. The potential to modify the pharmacokinetic behaviour of encapsulated drugs to deliver them selectively to the site of action is the most important feature of liposomes as drug delivery systems. Liposomes are already used in human medicine for he treatment of bacterial, viral and parasitic diseases, and cancer. They have also been proven useful as immunoadjuvants and vaccines. Liposomes are used in certain avian vaccines. The possible uses of liposomes and their impact in veterinary medicine in the treatment of infectious diseases and cancer as well as in the prevention of diseases are discussed in the present article.


Asunto(s)
Enfermedades de los Animales/tratamiento farmacológico , Liposomas , Medicina Veterinaria , Animales , Portadores de Fármacos , Humanos , Membrana Dobles de Lípidos
7.
s.l; s.n; apr. 1983. 7 p.
No convencional en Inglés | Sec. Est. Saúde SP, HANSEN, Hanseníase, SESSP-ILSLACERVO, Sec. Est. Saúde SP | ID: biblio-1240546

RESUMEN

The therapeutic efficacy of thalidomide in erythema nodosum leprosum suggests that thalidomide might play a useful therapeutic role in other human immune-complex diseases. Thalidomide has shown anti-inflammatory or immunosuppressive actions in several animal models. Current evidence suggests that its rapid activity in ENL may result from suppression of neutrophil chemotaxis and phagocytosis. Scattered anecdotal clinical reports of apparent response to thalidomide in various autoimmune diseases are hardly conclusive, but underline the desirability of appropriate pilot trials of thalidomide in autoimmune diseases, particularly those in which immune complex deposition plays a prominent role. Provided that a contraindication in fertile women is strictly observed, thalidomide therapy appears to be quite safe.


Asunto(s)
Femenino , Humanos , Animales , Cobayas , Ratas , Enfermedades Autoinmunes/tratamiento farmacológico , Enfermedades de los Animales/tratamiento farmacológico , Modelos Animales de Enfermedad , Rechazo de Injerto , Talidomida/uso terapéutico , Inflamación/tratamiento farmacológico , Inflamación/veterinaria
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA